Technical Analysis for RHHVF - Roche Holding AG

Grade Last Price % Change Price Change
grade C 350.0 0.29% 1.0000
RHHVF closed up 0.29 percent on Wednesday, July 8, 2020, on 11 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Flat
Historical RHHVF trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Cup with Handle Other 0.00%
Fell Below 20 DMA Bearish 0.29%
Fell Below 50 DMA Bearish 0.29%
180 Bearish Setup Bearish Swing Setup 0.29%
Cup with Handle Other 0.29%
50 DMA Support Bullish -1.27%
Cup with Handle Other -1.27%
Up 3 Days in a Row Strength -1.27%
Older signals for RHHVF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit
Health Pharmaceutical Industry Pharmaceuticals Life Sciences Pharmaceutical Industry In China Diabetes Infectious Diseases Chemotherapy Neuroscience Antibiotics Genentech Hoffmann La Roche In Vitro Diagnostics Diabetes Management Roche World Health Organization Personalised Healthcare Strategy Research Focused Healthcare Tissue Based Cancer

Is RHHVF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 399.0
52 Week Low 265.65
Average Volume 3,656
200-Day Moving Average 324.9105
50-Day Moving Average 351.5325
20-Day Moving Average 350.4184
10-Day Moving Average 350.0538
Average True Range 8.2274
ADX 12.18
+DI 17.6092
-DI 20.9846
Chandelier Exit (Long, 3 ATRs ) 337.3178
Chandelier Exit (Short, 3 ATRs ) 361.0222
Upper Bollinger Band 363.0253
Lower Bollinger Band 337.8115
Percent B (%b) 0.48
BandWidth 7.1953
MACD Line 0.2955
MACD Signal Line 0.5095
MACD Histogram -0.214
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 357.4100
Resistance 3 (R3) 357.9000 355.9200 356.1750
Resistance 2 (R2) 355.9200 354.0329 355.6750 355.7630
Resistance 1 (R1) 352.9600 352.8671 351.9700 352.4700 355.3515
Pivot Point 350.9800 350.9800 350.4850 350.7350 350.9800
Support 1 (S1) 348.0200 349.0929 347.0300 347.5300 344.6485
Support 2 (S2) 346.0400 347.9271 345.7950 344.2370
Support 3 (S3) 343.0800 346.0400 343.8250
Support 4 (S4) 342.5900